Sowell Financial Services LLC Has $323,000 Stock Position in IQVIA Holdings Inc. $IQV

Sowell Financial Services LLC grew its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 18.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,049 shares of the medical research company’s stock after acquiring an additional 320 shares during the quarter. Sowell Financial Services LLC’s holdings in IQVIA were worth $323,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in IQV. Pacer Advisors Inc. lifted its stake in shares of IQVIA by 5,036.1% in the 1st quarter. Pacer Advisors Inc. now owns 871,704 shares of the medical research company’s stock valued at $153,681,000 after acquiring an additional 854,732 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of IQVIA by 45.7% in the first quarter. JPMorgan Chase & Co. now owns 2,545,014 shares of the medical research company’s stock valued at $448,686,000 after buying an additional 798,534 shares during the period. Hawk Ridge Capital Management LP bought a new position in IQVIA in the 1st quarter valued at approximately $77,096,000. Nuveen LLC acquired a new stake in IQVIA during the 1st quarter worth approximately $76,328,000. Finally, GAMMA Investing LLC increased its position in IQVIA by 27,448.4% in the 1st quarter. GAMMA Investing LLC now owns 387,331 shares of the medical research company’s stock valued at $68,286,000 after acquiring an additional 385,925 shares during the period. 89.62% of the stock is owned by institutional investors.

Insider Transactions at IQVIA

In other IQVIA news, insider Eric Sherbet sold 5,800 shares of the business’s stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $190.05, for a total value of $1,102,290.00. Following the sale, the insider directly owned 27,178 shares in the company, valued at $5,165,178.90. The trade was a 17.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Keriann Cherofsky sold 549 shares of the business’s stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $191.53, for a total value of $105,149.97. Following the completion of the sale, the insider owned 2,910 shares in the company, valued at $557,352.30. This represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have commented on IQV. Evercore ISI lifted their target price on IQVIA from $170.00 to $180.00 and gave the stock an “outperform” rating in a report on Wednesday, July 9th. Redburn Partners set a $214.00 price objective on IQVIA in a research note on Wednesday, September 3rd. Cowen reissued a “buy” rating on shares of IQVIA in a research report on Wednesday, July 23rd. Mizuho upped their price objective on shares of IQVIA from $190.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, July 25th. Finally, Jefferies Financial Group upgraded shares of IQVIA from a “hold” rating to a “buy” rating and increased their price objective for the stock from $195.00 to $225.00 in a research report on Tuesday, September 9th. Eighteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, IQVIA currently has an average rating of “Moderate Buy” and an average target price of $229.64.

IQVIA Trading Down 2.5%

IQV opened at $176.72 on Friday. IQVIA Holdings Inc. has a fifty-two week low of $134.65 and a fifty-two week high of $237.34. The firm has a market capitalization of $30.04 billion, a PE ratio of 25.57, a P/E/G ratio of 1.99 and a beta of 1.32. The company has a debt-to-equity ratio of 2.45, a current ratio of 0.84 and a quick ratio of 0.84. The company’s 50-day moving average is $186.64 and its 200 day moving average is $167.31.

IQVIA (NYSE:IQV) last announced its quarterly earnings results on Tuesday, July 22nd. The medical research company reported $2.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.77 by $0.04. IQVIA had a return on equity of 30.05% and a net margin of 7.88%.The business had revenue of $4.02 billion during the quarter, compared to the consensus estimate of $3.96 billion. During the same quarter in the prior year, the company posted $2.64 earnings per share. IQVIA’s revenue was up 5.3% compared to the same quarter last year. IQVIA has set its FY 2025 guidance at 11.750-12.050 EPS. As a group, research analysts predict that IQVIA Holdings Inc. will post 10.84 earnings per share for the current fiscal year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.